Supply Chain

Richard Padzur, MD, will head the Oncology Center of Excellence, a program created under Vice President Joe Biden's Cancer Moonshot initiative to accelerate cancer research.

The Food and Drug Administration denied Lipocine's New Drug Application for its oral testosterone drug.

The Food and Drug Administration should eliminate its approve/disapprove method of reviewing new drug applications and instead use a Consumer Reports approach that is based on drug ratings, according to a column in the Wall Street Journal by John Sotos,…

Dublin, Ireland-based Medtronic recently filed for FDA approval on its new artificial pancreas device and expects to introduce the product to the market in 2017, according to Bloomberg.

The Food and Drug Administration on Tuesday approved Gilead Sciences' combination drug as the first available treatment for all six forms of hepatitis C.

The current healthcare environment is dynamic and challenging. Hospital System leadership needs to develop a strategy to improve care while reducing costs.

Orig3n, a Boston-based biotech company, is partnering with the San Francisco 49ers to reward football fans who support the company's human genome research.

Pfizer plans to build a $350 million biotech center in China in an effort to get its drugs to the Asian market faster, according to Reuters.

Roche's new multiple sclerosis drug earned priority review status from the Food and Drug Administration, potentially moving up the drug's launch date, according to Reuters.

Novartis will collaborate with Monrovia, Calif.-based Xencor to develop bispecific antibodies to treat cancer, according to Reuters.